Cited by 49Cancer, Hypoxia, and MetabolismNitric Oxide and Endothelin EffectsAngiogenesis and VEGF in Cancer

The acidic tumor microenvironment promotes the reconversion of nitrite into nitric oxide: towards a new and safe radiosensitizing strategy

Open access
Frérart, Françoise, Sonveaux, Pierre, Rath, Géraldine, Smoos, Alexandra, Meqor, Ahlam, Charlier, Nicolas, Jordan, Bénédicte F., Saliez, Julie +4 more·2008·Clinical Cancer Research

Abstract

PURPOSE: The biological status of nitrite recently evolved from an inactive end product of nitric oxide catabolism to the largest intravascular and tissue storage of nitric oxide (NO). Although low partial O(2) pressure favors enzymatic reconversion of nitrite into NO, low pH supports a nonenzymatic pathway. Because hypoxia and acidity are characteristics of the tumor microenvironment, we examined whether nitrite injection could preferentially lead to NO production in tumors and influence response to treatments. EXPERIMENTAL DESIGN: The effects of nitrite were evaluated on arteriole vasorelaxation, tumor cell respiration and tumor blood flow, oxygenation, and response to radiotherapy. RESULTS: We first showed that a small drop in pH (-0.6 pH unit) favored the production of bioactive NO from nitrite by documenting a higher cyclic guanosine 3',5'-monophosphate-dependent arteriole vasorelaxation. We then documented that an i.v. bolus injection of nitrite to tumor-bearing mice led to a transient increase in partial O(2) pressure in tumor but not in healthy tissues. Blood flow measurements failed to reveal an effect of nitrite on tumor perfusion, but we found that O(2) consumption by nitrite-exposed tumor cells was decreased at acidic pH. Finally, we showed that low dose of nitrite could sensitize tumors to radiotherapy, leading to a significant growth delay and an increase in mouse survival (versus irradiation alone). CONCLUSIONS: This study identified low pH condition (encountered in many tumors) as an exquisite environment that favors tumor-selective production of NO in response to nitrite systemic injection. This work opens new perspectives for the use of nitrite as a safe and clinically applicable radiosensitizing modality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-07-4001

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nitrite selectively induces a transient increase in tumor partial O2 pressure (pO2).

    “It was found that nitrite selectively induce a transient increase in tumor partial O2 pressure (pO2), which improved the efficacy of radiotherapy.”
  • Nitrite-induced transient increase in tumor pO2 improved the efficacy of radiotherapy.

    “It was found that nitrite selectively induce a transient increase in tumor partial O2 pressure (pO2), which improved the efficacy of radiotherapy.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Frérart, F., Sonveaux, P., Rath, G., Smoos, A., Meqor, A., Charlier, N., Jordan, B. F., Saliez, J., Noël, A., Dessy, C., Gallez, B., & Feron, O.
Affiliations
  • 1Pharmacology and Therapeutics, Université catholique de Louvain, UCL-FATH and Unit of
  • UCLouvain (BE)
  • 2Biomedical Magnetic Resonance, Université catholique de Louvain, UCL-REMA, Brussels, Belgium; and
  • 3Laboratory of Tumor and Developmental Biology, University of Liège, Tour de Pathologie (B23), Sart-Tilman, Belgium
Venue
Clinical Cancer Research
Published
2008-05-01
Volume
14
Issue
9
Pages
2768-2774
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2153330586
Cited by
49
References
47
Citations by year
2026: 2 · 2025: 1 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 3
FWCI
1.35
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Open Repository and Bibliography (University of Liège) (submittedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
nitrite, nitric oxide, tumor acidosis, radiosensitization, radiotherapy, tumor hypoxia, tumor oxygenation, tumor cell respiration, vasorelaxation, cyclic GMP, tumor perfusion
MeSH terms
Animals, Blood Vessels, Hydrogen-Ion Concentration, Liver Neoplasms, Male, Mice, Inbred Strains, Nitric Oxide, Nitrites, Oxygen Consumption, Radiation-Sensitizing Agents, Vasodilation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review